Full Text View
Tabular View
No Study Results Posted
Related Studies
Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?
This study is ongoing, but not recruiting participants.
First Received: December 3, 2008   Last Updated: December 4, 2008   History of Changes
Sponsored by: Vanderbilt University
Information provided by: Vanderbilt University
ClinicalTrials.gov Identifier: NCT00802633
  Purpose

Evaluate the utility/safety of an FDA-approved tissue sealing device during radical cystectomy as compared to an FDA-approved stapling device.


Condition Intervention
Bladder Cancer
Hemostasis
Device: Stapling device during radical cystectomy
Device: Ligasure tissue sealing device

Genetics Home Reference related topics: bladder cancer
MedlinePlus related topics: Bladder Cancer Cancer Surgery
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind (Subject), Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?

Further study details as provided by Vanderbilt University:

Primary Outcome Measures:
  • Blood loss [ Time Frame: Perioperative ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Operative Time [ Time Frame: Intraoperative time ] [ Designated as safety issue: No ]

Enrollment: 20
Study Start Date: November 2008
Estimated Study Completion Date: November 2009
Estimated Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Stapling device
Device: Stapling device during radical cystectomy
Hemostasis
2: Experimental
Efficacy of ligasure tissue sealing device during radical cystectomy
Device: Ligasure tissue sealing device
Efficacy of tissue sealing device during hemostasis

  Eligibility

Ages Eligible for Study:   19 Years to 85 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Muscle invasive bladder cancer
  • Male gender

Exclusion Criteria:

  • Female gender
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00802633

Locations
United States, Tennessee
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232
Sponsors and Collaborators
Vanderbilt University
  More Information

No publications provided

Responsible Party: Vanderbilt University Medical Center ( Carl Bischoff, MD )
Study ID Numbers: 081018
Study First Received: December 3, 2008
Last Updated: December 4, 2008
ClinicalTrials.gov Identifier: NCT00802633     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by Vanderbilt University:
Tissue sealing device
Articulating stapling device
Radical cystectomy

Study placed in the following topic categories:
Urinary Tract Neoplasm
Cystocele
Urologic Diseases
Urinary Bladder Diseases
Urinary Bladder Neoplasms
Urogenital Neoplasms
Bladder Neoplasm
Urologic Neoplasms
Hemostatics

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site
Urologic Diseases
Urinary Bladder Diseases
Urinary Bladder Neoplasms
Urogenital Neoplasms
Urologic Neoplasms

ClinicalTrials.gov processed this record on May 07, 2009